Abstract

Rheumatoid arthritis is a chronic systemic autoimmune disorder and the drugs used to treat are taken for a long period of time, so it is necessary to ensure that Rheumavedic (RV) capsule, used to treat rheumatoid arthritis, is free from any toxicity. The present study was taken up to evaluate the genotoxic potential of RV capsule. Swiss albino mice (25–30 g) were divided into eight groups (n=6). Control mice received vehicle (2 ml distilled water, p.o.), Group II, III, IV mice received cyclophosphamide (CPA) dissolved in vehicle, Group V animals received RV (780 mg/kg,p.o.×7 days), Group VI, VII, VIII animals received RV for seven days followed by CPA on the 7th day. Animals were sacrificed after 24 (Group II and VI), 48 (Group III and VII) and 72 h (Group IV and VIII) of CPA challenge. Bone marrow micronucleus test (MNT) and chromosomal aberration test was carried out against CPA-induced clastogenicity (100 mg/kg, IP) in mouse. One-way ANOVA, Post-hock analysis by Tukey’s multiple comparison tests was done using GraphPad Prism 5. There was no significant decrease in micronucleus formation and chromosomal aberrations in RV-treated mice against CPA-induced clastogenicity. RV is free of genotoxicity, but do not have antigenotoxic effect. Key words: Bone marrow, chromosomal aberrations, cyclophosphamide, Rheumavedic, micronucleus

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.